2026-01-19 - Analysis Report
# Financial Report for Northrop Grumman (NOC)

## Simple Numbers

- **Company Overview**: Northrop Grumman specializes in defense, aerospace, unmanned systems, and missile technologies.
  
### Comparison with S&P 500 (VOO)
- **Cumulative Return of NOC**: 35.84%
- **Cumulative Return of VOO**: 82.54%
- **Divergence**: -46.70% (NOC underperformed compared to VOO)

### Alpha, Beta Analysis
| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
|------------|--------|-------|--------|-------|--------|
| 2016-2018  | -15.0% | 20.9% | -15.0% | 0.7   | 35.1B  |
| 2017-2019  | -14.0% | 20.9% | -23.0% | 0.7   | 49.2B  |
| 2018-2020  | -31.0% | 20.9% | -52.0% | 0.8   | 43.6B  |
| 2019-2021  | 21.0%  | 14.6% | -16.0% | 0.7   | 55.4B  |
| 2020-2022  | 17.0%  | 14.6% | 7.0%   | 0.6   | 78.1B  |
| 2021-2023  | 13.0%  | 14.6% | -3.0%  | 0.3   | 67.0B  |
| 2022-2024  | -7.0%  | 13.9% | -33.0% | 0.3   | 67.2B  |
| 2023-2025  | 11.0%  | 14.4% | -38.0% | 0.1   | 81.6B  |

### Recent Stock Price Fluctuations
- **Close Price**: $666.90
- **Last Market Price**: $666.90
- **Previous Close**: $654.61
- **Change**: $1.88
- **5-day SMA**: $645.89
- **20-day SMA**: $599.93
- **60-day SMA**: $579.36

### RSI, PPO Index, and Expected Return
- **Market Risk Indicator (MRI)**: 0.80 (Medium Investment)
- **RSI**: 74.74
- **PPO**: 1.29
- **Hybrid Signal**: Buy (Cash 1%)
- **Recent Relative Divergence Change**: 0.0 (flat)
- **7-day Rank Change**: 0 (flat)
- **Expected Return (%)**: N/A

### Recent News & Significant Events
- [2026-01-18] Massachusetts Financial Services Co. MA Sells 33,325 Shares of Northrop Grumman Corporation (link)
- [2026-01-08] Whatâ€™s The Risk For Northrop Grumman Stock As Trump Curbs Dividends And Executive Pay? (link)
- [2026-01-13] Northrop Grumman: $1.5 Trillion Defense Budget Boosts F/A-XX Win (Rating Upgrade) (link)
- [2026-01-08] Stocks making the biggest moves premarket: Lockheed Martin, Northrop Grumman, Gap, Alcoa & more (link)
- [2026-01-15] Northrop Grumman Stock Hits All-Time High, Gets Rating Upgrade (link)
- [2026-01-16] Northrop Grumman (NOC) Is Up 10.8% After Winning Marine Corps Valkyrie MUX Autonomy Contract (link)

### Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.09 (~Buy)
- Opinions: 21
- Target Price (avg/high/low): 674.92 / 777.00 / 576.00
```

### Recent Earnings Analysis
| Date       | EPS   | Revenue   |
|------------|-------|-----------|
| 2025-10-21 | 7.69  | 10.42 B$  |
| 2025-07-22 | 8.17  | 10.35 B$  |
| 2025-04-22 | 3.33  | 9.47 B$   |
| 2024-10-24 | 7.02  | 10.00 B$  |
| 2025-10-21 | 7.02  | 10.00 B$  |

### Financial Information
#### Revenue and Profitability
| Quarter     | Revenue | Profit Margin |
|-------------|---------|---------------|
| 2025-09-30  | $10.42B | 21.37%        |
| 2025-06-30  | $10.35B | 21.35%        |
| 2025-03-31  | $9.47B  | 16.69%        |
| 2024-12-31  | $10.69B | 18.08%        |
| 2024-09-30  | $10.00B | 21.07%        |

#### Capital and Profitability
| Quarter     | Equity  | ROE   |
|-------------|---------|-------|
| 2025-09-30  | $15.99B | 6.88% |
| 2025-06-30  | $15.47B | 7.59% |
| 2025-03-31  | $14.98B | 3.21% |
| 2024-12-31  | $15.29B | 8.27% |
| 2024-09-30  | $14.75B | 6.96% |

### Comprehensive Analysis
- Northrop Grumman's cumulative return significantly lags behind the S&P 500.
- Recent stock price shows a slight increase with SMA indicating upward trends.
- Analyst consensus leans towards a 'Buy' stance with a target price indicating potential growth.
- Recent earnings show fluctuating EPS and stable revenue growth with a decent profit margin. 
- Medium risk level suggests a cautious investment approach.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.